Bio-Techne
TECH
#2150
Rank
NZ$15.49 B
Marketcap
NZ$99.05
Share price
0.79%
Change (1 day)
-12.76%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Earnings for Bio-Techne (TECH)

Earnings in 2025 (TTM): NZ$0.21 Billion

According to Bio-Techne's latest financial reports the company's current earnings are NZ$1.21 Billion. a decrease over its 2024 earnings that were of NZ$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bio-Techne from 1991 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.20 B-37.2%
2024 NZ$0.32 B-26.01%
2023 NZ$0.43 B-19.25%
2022 NZ$0.54 B50.77%
2021 NZ$0.36 B-1.3%
2020 NZ$0.36 B-15.46%
2019 NZ$0.43 B82.56%
2018 NZ$0.23 B11.13%
2017 NZ$0.21 B1.19%
2016 NZ$0.21 B-12.64%
2015 NZ$0.24 B-9.33%
2014 NZ$0.26 B2.19%
2013 NZ$0.26 B-1.7%
2012 NZ$0.26 B-3.5%
2011 NZ$0.27 B6.2%
2010 NZ$0.25 B-0.59%
2009 NZ$0.25 B2.78%
2008 NZ$0.25 B14.95%
2007 NZ$0.21 B15.14%
2006 NZ$0.19 B11.66%
2005 NZ$0.17 B17.05%
2004 NZ$0.14 B18.06%
2003 NZ$0.12 B26.06%
2002 NZ$98.2 M22.66%
2001 NZ$80.06 M9.92%
2000 NZ$72.83 M43.92%
1999 NZ$50.6 M31.99%
1998 NZ$38.34 M29.61%
1997 NZ$29.58 M31.62%
1996 NZ$22.47 M34.65%
1995 NZ$16.69 M16.09%
1994 NZ$14.37 M29.85%
1993 NZ$11.07 M6.35%
1992 NZ$10.41 M152%
1991 NZ$4.13 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
NZ$11.72 B 5,646.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$3.11 B 1,424.13%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$17.92 B 8,681.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$7.34 B 3,500.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$0.89 B 338.30%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-NZ$12.96 Million-106.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-NZ$1.4 Billion-782.39%๐Ÿ‡บ๐Ÿ‡ธ USA